Gate2Brain
  • Home
  • Company
  • Team
  • Technology
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

THIS IS HOW A DRUG IS TOWED TO THE BRAIN

News
THIS IS HOW A DRUG IS TOWED TO THE BRAINExpansión

Sometimes drugs need a special push to be more effective and reach its final destination: the brain. The three families of peptides (proteins) developed and patented by Gate2Brain fullfil that mission by acting as a shuttle or tractor so that the medicines act on this organ and treat pathologies located in it. This development, after years of work, has been possible thanks to a team of researchers and professionals from the Universitat de Barcelona, ​​the IRB Barcelona and the Hospital Sant Joan de Déu Barcelona, led by Meritxell Teixido, CEO of Gate2Brain.

“The first application of this technology will be for the treatment of pediatric cancer, when it is located in the brain. We are currently in the preclinical phase and the first clinical trial with pediatric patients is scheduled for 2026 at the Sant Joan de Déu Hospital, a reference center for childhood diseases”, explains Teixidó. However, the applications of these tractors are more ambitious and, as this researcher points out, they could serve to improve the transport of other drugs to the brain to address diseases such as Parkinson’s or Alzheimer’s: “The idea is to reach agreements with large pharmaceutical companies to test our technology with their drug candidates”, she adds.

 

Source: https://www.expansion.com

December 19, 2022/by noticias
Tags: Expansión, Gate2Brain, pediatriccancer, research, Startup
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2022/12/Gradient-Professional-Linkedin-Profile-Picture-2.png 1080 1080 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2022-12-19 18:18:392022-12-19 18:21:38THIS IS HOW A DRUG IS TOWED TO THE BRAIN
You might also like
Gate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day 🗣️at the University of Cambridge, the cradle of cancer research. The MTI Pitch Day is a great initiative designed to highlight companies like us to investors, to create connections between academic entrepreneurship and investment to promote therapeutic companies. A great event that pulls together on one side academic, preclinical and research and on the other industry in an effort to push forward collaborative drug development and increase the standard of patient care Gate2Brain at MIT Pitch Day at University of Cambridge
GATE2BRAIN winner of the Barcelona Activa Pre-acceleration competitionBarcelona Activa GATE2BRAIN WINNER OF THE BARCELONA ACTIVA PRE-ACCELERATION COMPETITION
la start-up catalana una de las ganadoras del South Summit de salud en Valenciala Vanguardia Gate2Brain one of the winners of the South Summit Health & Well-being
Meritxell Teixidó això de semblar una superwomen em patina moltDiari Ara I couldn’t care less about looking like a “superwoman”
BioSpain2021 Gate2Brain attending BioSpain 2021
Meritxell Teixidó (Gate2Brain, Medicines Beyond Barriers): “Utilitzem una nova tecnologia basada en pèptids per millorar el transport de fàrmacs al cervell” Meritxell Teixidó (Gate2Brain, Medicines Beyond Barriers): “We use a new technology based on peptides to improve the transport of drugs to the brain”
Womenstartupawardsgate2Brain WomenStarUpAwards
desafio singaporeICEX Desafía Singapore

CATEGORIES

  • Clipping
  • Events
  • News
  • Podcast
  • Press releases
  • Publications
  • Videos

Events

  • 📢 On December 13h, Gate2Brain will be participating together with Maribel Berges (AFFIRMA BIOTECH SL), Sven Dr. Mulfinger (Dana_positive maternal health), and Diana Ballart (The Smart Lollipop) in the i4kids Closing Event 2022, sharing achievements and failures of entrepreneurs in #pediatric and maternal #healthcare.i4kidsi4kids Closing Event 2022December 7, 2022 - 12:37
  • WomenStartupAwards, in the "Inspiration" category.WomeninTechSpainFinalist of Women Startup AwardsNovember 15, 2022 - 17:46
  • GORDON CONFERENCESgate2brainGordon Research ConferencesNovember 3, 2022 - 11:41
  • Gate2Brain's retreat 2022Gate2BrainGate2Brain’s retreat 2022October 24, 2022 - 19:27
  • BIO EUROPE 2022GATE2BRAINGate2Brain at BIO-EUROPE 2022September 22, 2022 - 13:39

SOCIAL

  • linkedin
  • youtube

RSS RSS Ciencia

  • What will the d·Health Barcelona Part Time program clinical immersion be like? January 24, 2023 biocat
  • Good start to the year in investment and advances in projects at science facilities January 24, 2023 biocat
  • AseBio and Biocat present BIOSPAIN 2023 in Barcelona to over 200 people from the sector January 16, 2023 biocat
  • 2022: Healthcare research and innovation are strategic priorities for Catalonia December 23, 2022 biocat
  • 5th edition of CRAASH Barcelona program comes to an end December 21, 2022 biocat
  • Registration now open for presentation of 2022 BioRegion Report December 20, 2022 biocat
  • Open Innovation Forum consolidates role resolving innovation challenges in BioRegion December 20, 2022 biocat
  • AseBio and Biocat to present BIOSPAIN 2023 in Barcelona at public event open to whole ecosystem December 12, 2022 biocat
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Sometimes the impossible only comes later Team Sant Joan de Deu Gate2Brain receives €2,5M funding to develop a technology that enhances drug...
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}